Securities Code: 301075
Securities Abbreviation: Duorui Pharmaceutical
Announcement Number: 2026-054
Tibet Duorui Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Recently, the Company received a notification from Tibet Jiakang Times Technology Development Co., Ltd. (hereinafter referred to as "Tibet Jiakang"), a shareholder holding over 5% of the Company's shares, informing that Tibet Jiakang has lifted the pledge on part of its shares. The specific details are as follows: